from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2647/-

LFCtreatmentdescriptionclass of inhibitor

0.418

Amikacinug/mL Amikacintranslation

-0.055

Cap5-10ug/mL Capreomycintranslation

0.914

Rox10-50 ug/mL Roxithromycintranslation

-1.041

SM2-5 ug/mL Streptomycintranslation

-0.591

Tet5-10 ug/mL Tetracyclinetranslation

-0.234

Rif0.2-5ug/mL Rifampicintranscription

-0.287

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.138

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.779

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.177

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.313

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.127

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.933

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.069

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.352

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.064

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.388

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.800

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.154

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.266

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.278

KCN5-20 ug/mL Potassium cyaniderespiration

-0.151

NaN30.2-2 mM Sodium aziderespiration

0.152

Nigericin50 uM Nigericinrespiration

-0.240

TRC10-150 ug/mL Triclosanrespiration

1.287

TRZ10-25 ug/mL Thioridazinerespiration

3.565

Valinomycin0.5-10 uM Valinomycinrespiration

-1.401

ZnSO42 mM ZnSO4respiration

-0.292

menadione6-10 ug/mL Menadionerespiration

-0.061

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.192

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.206

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.320

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.643

NRP_1Non-replicating persistence stage 1dosRassociated

-0.475

Amp0.2mg/mL AmpicillincellWall

-0.188

Cephalexin20-100 ug/mL CephalexincellWall

0.238

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.794

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.493

EMB10-20 ug/mL EthambutolcellWall

-0.186

Eta12-40 ug/mL EthionamidecellWall

-0.281

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.317

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.084

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.293

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.431

BZA0.12 mg/mL BenzamidearomaticAmides

-0.069

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.067

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.134

H2O24 mM hydrogen peroxideDNAdamaging

-0.238

Levo10 ug/mL LevofloxacinDNAdamaging

-0.585

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.698

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.101

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.501

UVUV-irradiationDNAdamaging

0.420

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.666

Antimycin12.5-50 ug/mL Antimycin A?

-0.143

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.054

PA_110-50 ug/mL Antitubercular compound PA-1?

0.325

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.388

PA8240.2-2 ug/mL PA-824?

0.306

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.170

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.091

Verapamil50 uM Verapamil?

-0.181

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.031

methoxatin10-20 ug/mL Methoxatin?